Such promising results are encouraging, and it indicates that GLP1-R molecular imaging is gradually replacing conventional imaging as the non-invasive modality of choice for the accurate preoperative localization of insulinoma. This evidence concerns the gene GLP1R and pancreatic insulinoma.